How China weaponized soybeans to squeeze US farmers—and spite Trump
President Donald Trump on social media called China’s decision to not buy soybeans “an Economically Hostile Act” amid its trade war with the U.S.
The Washington Post
Articles
Amazon says outage has subsided after major internet disruption
By 6:35 a.m. Eastern time, the company said the issue had been “fully mitigated,” but later said some of its services are “still experiencing elevated errors.”
Indiana University and its student paper are at odds on press freedom
On Thursday, the front page of the Daily Student, which ran online only, was topped with huge letters in red: “CENSORED.”
Chamber of Commerce sues Trump to block $100,000 fee for H-1B visas
The chamber’s lawsuit is not the first against the new visa fee, but it’s significant because it marks the first by the chamber, one of the most powerful and largest business groups in Washington.
Two industries were supposed to drive America’s future. One is booming, the other slumping.
Both fields have been in the spotlight in Washington through successive administrations, but appear to be heading in different directions.
Americans can’t stop betting parlays. Sportbooks are cashing in.
Bettors lose billions of dollars a year on parlays, the data shows, and operators bring in far more revenue for every dollar wagered on these bets than they do straight bets.
Airport staffing shortages causing some flight delays a week into shutdown
According to flight-tracking website FlightAware, more than 6,140 U.S. flights were delayed Monday.
CDC recommends coronavirus vaccine with new caveat. Here’s what to know.
The Centers for Disease Control and Prevention on Monday said it had officially recommended updated COVID vaccines, creating a new system to get a shot that’s slightly more complicated than in previous years.
Senate returns with no shutdown deal in sight
Senators on Monday defeated two proposals to end the government shutdown on its sixth day.
Trump administration resumes student loan forgiveness
Even as the Education Department reopens loan forgiveness, the ongoing government shutdown could slow the agency’s ability to process discharges quickly.
Companies might find ways to avoid Trump’s new $100,000 visa
The H-1B visa is popular among tech companies, with Amazon, Microsoft and information technology contractors like Infosys and Cognizant among some of the largest users.
As stock market booms, Americans have more at stake than ever
Data from the Federal Reserve Bank of St. Louis showed that households and nonprofits were investing about 45.4% of their assets in corporate equities as of the second quarter of 2025—the highest exposure to stocks ever.
Trump to announce drug-pricing deal with Pfizer, new ‘TrumpRx’ website
The announcements are part of an effort to secure “Most Favored Nation” pricing deals with pharmaceutical manufacturers, an effort to link U.S. drug prices to the lowest cost of drugs paid by the wealthiest countries.
Trump posts video endorsing CBD for seniors. Researchers urge caution.
The video jolted the cannabis industry, sending stocks soaring and raising hopes that the president will take a permissive approach to marijuana.
Shutdown nears as Trump meeting yields no breakthrough with Congress
If Congress fails to approve a funding extension by the end of Tuesday, spending laws will expire and the U.S. government will become a bare-bones operation, continuing only functions necessary to protect life or public property.
What new tariffs mean for pharmaceuticals, patented drugs
President Donald Trump’s announcement that his administration will impose a 100 percent tariff on patented pharmaceutical products sparked confusion Friday, as government officials, drug companies and trade groups sought clarity on how the levy would be applied.
Looming federal shutdown: Mass layoffs, fewer regulations and military deployments
Federal funds expire when the fiscal year ends Tuesday night, and Congress appears deadlocked over a stopgap measure that would keep agencies online for seven weeks while long-term negotiations continue.
Trump’s corporate tax break worth $67B hits Biden-era snag
Trump’s recently enacted tax law sweetened a break for corporate research and development investments, a provision especially valuable to technology, pharmaceutical and manufacturing businesses. But some businesses won’t be able to take full advantage of the break.
Weight-loss drugs can cut future health costs. The fight is over who pays now.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market
Ahead of decisions by the FDA, both Novo Nordisk and Eli Lilly are readying production for their weight-loss pills, having been unable to keep up with demand for their shots that exploded in popularity.